Interview: Paweł Mazur – East Area Director, Accord Healthcare, Poland
As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top…
Address: ul. Jutrzenki 94
02-230 Warszawa
Tel: +48 22 824 97 32
Web: http://www.blaufarma.pl/?pId=produkty_glowna
Founded in 2001, BLAU FARMA is Polish private specialty pharmaceutical company focused on dermatology.
The company is centered on development, manufacturing and marketing of innovative, safe and effective prescription and over-the-counter preparations that importantly improve the lives of patients suffering from conditions related to skin diseases (such as acne, steroid-sensitive dermatoses, fungal and bacterial infections), as well as dermocosmetics lines of products that aid each individual to optimize their skin’s health.
The second BLAU FARMA’s business area is parallel import of medicinal products. Today, the company is parallel importer No 3 in Poland. We strongly believe that stimulating competition in the pharmaceutical market enables broader access to better treatment options for greater number of patients.
Quality is a cornerstone of all BLAU FARMA’s of activities. The company seeks the highest quality information, decisions and people, and produces high quality products.
BLAU FARMA’s goal is to become the number one in Poland among dermatology-focused pharmaceutical companies and to enter European export markets.
With the headquarter in Warsaw, BLAU FARMA employs 56 highly skilled and efficient full-time employees.
The company holds integrity, responsibility and professionalism above all else. Also cherishes hard work, productivity, loyalty, accountability, leadership, teamwork, creativity, initiative, courage, enthusiasm and optimism.
Prescription and non prescription pharmaceutical in dermatology.
Parallel imports of dermatology products as well as expanding ophthamological products.
As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top…
Krzysztof Popławski, general manager of Baxter Poland, discusses the Baxter Education Center, the largest educational program for a European affiliate, and its role in raising the awareness within the Polish…
Hubert Niemyjski, country manager of Coloplast Poland and the Baltics, highlights the large differences between the market landscape of the company’s three pillars; ostomy, wound and continence care. Additionally, he…
Olympus is internationally well-regarded as being a quality camera provider and continues to provide developed countries across the globe with high-tech medical devices from endoscopes to imagery solutions. Tomasz Mrzygłód,…
Paweł Migdalski, CEO at Siemens Healthineers Poland, discusses the innovations they are bringing to the market and how they are building on the success of the Siemens Healthineers Academy. Furthermore,…
Tomasz Dzitko, founder and CEO of Delfarma, Poland’s leading parallel importer, gives an overview of the sector in Poland and its impact on the healthcare ecosystem, as well as the…
Piotr Steczniewski, president of Profarm PS – a successful wholesale family business – since 2012, shares how the company has managed to thrive over the years through constant adaptation to…
Łukasz Korybalski, regional manager of Becton Dickinson (BD) Central Eastern Europe, discusses the rising significance of the region as the company continues to grow and the strategic importance of Poland,…
Marzena Kulis, managing director of Johnson & Johnson Medical Devices CEE, highlights the importance of the region and Poland within J&J Medical Devices, and the impact of increasing healthcare expenditures…
Despite the global R&D excitement around oncology, cardiovascular death still remains the world’s largest killer, and according to OECD data, accounts for roughly a third of all mortalities. This trend…
Cezary Kilczewski, president and founder of Medicofarma, a Polish CMO, discusses the company’s recent upgrades to double production capacity and the move into R&D operations as well as the dynamics…
Andrzej Schonert, CEO of Synoptis Industrial, discusses the intricacies of the Polish market and the requirement to move into niche areas, mainly in Rx, to concentrate their pharmaceutical offering to…
See our Cookie Privacy Policy Here